Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 1
1951 4
1952 2
1953 2
1954 1
1955 1
1957 2
1959 1
1964 1
1965 1
1967 4
1969 1
1970 1
1971 1
1972 2
1976 1
1978 1
1979 1
1982 1
1986 1
1989 1
1990 3
1991 2
1992 2
1993 1
1994 4
1995 1
1996 1
1997 6
1998 3
1999 3
2000 6
2001 11
2002 13
2003 11
2004 10
2005 15
2006 24
2007 14
2008 25
2009 29
2010 34
2011 33
2012 33
2013 32
2014 46
2015 63
2016 63
2017 66
2018 104
2019 111
2020 122
2021 101
2022 94
2023 90
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

1,094 results

Results by year

Filters applied: . Clear all
Page 1
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L(Rx) (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy.
Coelho T, Ando Y, Benson MD, Berk JL, Waddington-Cruz M, Dyck PJ, Gillmore JD, Khella SL, Litchy WJ, Obici L, Monteiro C, Tai LJ, Viney NJ, Buchele G, Brambatti M, Jung SW, St L O'Dea L, Tsimikas S, Schneider E, Geary RS, Monia BP, Gertz M. Coelho T, et al. Neurol Ther. 2021 Jun;10(1):375-389. doi: 10.1007/s40120-021-00235-6. Epub 2021 Feb 26. Neurol Ther. 2021. PMID: 33638113 Free PMC article.
All patients will then receive AKCEA-TTR-L(Rx) through the remainder of the study treatment period. The final efficacy analysis at week 66 will compare the AKCEA-TTR-L(Rx) arm with the historical placebo arm from the phase 3 trial of inotersen (NEURO-TTR). ...People …
All patients will then receive AKCEA-TTR-L(Rx) through the remainder of the study treatment period. The final efficacy analysis at we …
Le retour en classe et le port du masque pendant la pandémie de COVID-19 : le point de vue des élèves d’après une étude de simulation scolaire.
Coelho SG, Segovia A, Anthony SJ, Lin J, Pol S, Crosbie J, Science M, Matava CT, Parekh RS, Caldeira-Kulbakas M, Carroll S, Greenwood JL, Panzera G, Imgrund R, Osokin K, Korczak DJ. Coelho SG, et al. Paediatr Child Health. 2022 Sep 8;27(Suppl 2):S95-S102. doi: 10.1093/pch/pxac017. eCollection 2022 Sep. Paediatr Child Health. 2022. PMID: 36092299 Free PMC article. French.
Corrigendum.
[No authors listed] [No authors listed] J Cereb Blood Flow Metab. 2016 Feb;36(2):457. doi: 10.1177/0271678X15619790. J Cereb Blood Flow Metab. 2016. PMID: 26814200 Free PMC article.
The TNF-alpha/NF-kappaB signaling pathway has a key role in methamphetamine-induced blood-brain barrier dysfunctionVanessa Coelho-Santos, Ricardo A Leitao, Filipa L Cardoso, Ines Palmela, Manuel Rito, Marcos Barbosa, Maria A Brito, Carlos A Fontes-Ribeiro and Ana P …
The TNF-alpha/NF-kappaB signaling pathway has a key role in methamphetamine-induced blood-brain barrier dysfunctionVanessa Coelho-San …
Abdominal Imaging Findings after Radiation Therapy.
Coelho FMA, Rodrigues LBQ, Panizza PSB, Médici CTM, de Mello Ando S, Mauro GP, de Souza Rocha M, Yamauchi FI, Viana PCC. Coelho FMA, et al. Radiographics. 2020 Jan-Feb;40(1):120-121. doi: 10.1148/rg.2020190128. Radiographics. 2020. PMID: 31917656 Review. No abstract available.
Acoustic analysis of parkinsonian speech II: L-Dopa related fluctuations and methodological issues.
Goberman AM, Coelho C. Goberman AM, et al. NeuroRehabilitation. 2002;17(3):247-54. NeuroRehabilitation. 2002. PMID: 12237506 Review.
The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa. ...Strategies are proposed for addressing these methodological issues in studying the effects of …
The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after …
Re: ultrasound guidance during embryo transfer: a systematic review and meta-analysis of randomized controlled trials. D. M. Teixeira, L. A. Dassuncao, C. V. R. Vieira, M. A. P. Barbosa, M. A. Coelho Neto, C. O. Nastri and W. P. Martins. Ultrasound Obstet Gynecol 2015; 45: 139-148.
Drakeley A. Drakeley A. Ultrasound Obstet Gynecol. 2015 Feb;45(2):131. doi: 10.1002/uog.14765. Ultrasound Obstet Gynecol. 2015. PMID: 25627095 Free article. No abstract available.
Platelet activation and antimicrobial activity of L-PRF: a preliminary study.
Melo-Ferraz A, Coelho C, Miller P, Criado MB, Monteiro MC. Melo-Ferraz A, et al. Mol Biol Rep. 2021 May;48(5):4573-4580. doi: 10.1007/s11033-021-06487-7. Epub 2021 Jun 19. Mol Biol Rep. 2021. PMID: 34146200
Leukocyte and platelet rich fibrin (L-PRF) is one of the platelet concentrates used to support regeneration and healing process. ...In our opinion, the use of L-PRF exudate, in addition to L-PRF membrane, presents some advantages that have to be considered in …
Leukocyte and platelet rich fibrin (L-PRF) is one of the platelet concentrates used to support regeneration and healing process. ...I …
COVID-19-Associated Chemosensory Loss Continues to Decline.
Reiter ER, Coelho DH, French E, Costanzo RM; N3C Consortium. Reiter ER, et al. Otolaryngol Head Neck Surg. 2023 Nov;169(5):1386-1389. doi: 10.1002/ohn.384. Epub 2023 May 26. Otolaryngol Head Neck Surg. 2023. PMID: 37232470 Free PMC article.
Using rates of chemosensory loss during the peak time interval for "Untyped" variants as baseline (4/27/2020-6/18/2020), odds ratios for COVID-19-associated smell or taste disturbance fell for each of the Alpha (0.744), Delta (0.637), Omicron K (0.139), Omicron L (0.079), …
Using rates of chemosensory loss during the peak time interval for "Untyped" variants as baseline (4/27/2020-6/18/2020), odds ratios for COV …
L-Alanyl-Glutamine Attenuates Oxidative Stress in Liver Transplantation Patients.
Barros MA, Vasconcelos PR, Souza CM, Andrade GM, Moraes MO, Costa PE, Coelho GR, Garcia JH. Barros MA, et al. Transplant Proc. 2015 Oct;47(8):2478-82. doi: 10.1016/j.transproceed.2015.08.001. Transplant Proc. 2015. PMID: 26518955 Clinical Trial.
The objective of this randomized, double-blind study was to evaluate the possible protective effects of L-alanyl-glutamine on the liver graft. METHODS: The sample included 33 patients from a liver transplantation service in Northeastern Brazil. Before cold ischemia, the pa …
The objective of this randomized, double-blind study was to evaluate the possible protective effects of L-alanyl-glutamine on the liv …
1,094 results